Loading
Latest filing published 29 May 2020 for Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.), €2,968.
All filings by Michael Brooks on record concern Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Over a trading history stretching from 8 January 2020 to 27 May 2020, the count stands at 3 filings.
On the market, this insider has only ever bought: 2 purchases, €4,948 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 29 May 2020 with an open-market purchase (€2,968) in Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.). Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations